Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 3/20 | 0.62 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.61 |
| ▸ | PKM | P14618 | 2/20 | 0.61 |
| ▸ | ALPI | P09923 | 1/20 | 0.61 |
| ▸ | XIAP | P98170 | 1/20 | 0.61 |
| ▸ | HIF1A | Q16665 | 5/20 | 0.53 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.53 |
| ▸ | USP2 | O75604 | 1/20 | 0.53 |
| ▸ | EGFR | P00533 | 1/20 | 0.53 |
| ▸ | LCK | P06239 | 1/20 | 0.53 |
| ▸ | FYN | P06241 | 1/20 | 0.53 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.53 |
| ▸ | HTR2A | P28223 | 1/20 | 0.53 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.53 |
| ▸ | RECQL | P46063 | 1/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.53 |
| ▸ | TPH1 | P17752 | 1/20 | 0.53 |
| ▸ | GRB2 | P62993 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12015202 | 1.00 | SLC7A5 (0.62) | SLC7A5PTGS1PKMALPIXIAP | |
| SCHEMBL2310526 | 0.84 | SLC7A5 (0.83) | SLC7A5PTGS1PKMALPIXIAP | |
| Tyrosine SCHEMBL28820995 | 0.79 | SLC7A5 (0.96) | SLC7A5PTGS1PKMALPIXIAP | |
| Tyrosine SCHEMBL28428764 | 0.79 | SLC7A5 (0.96) | SLC7A5PTGS1PKMALPIXIAP | |
| Hydrochloric Acid SCHEMBL28269648 | 0.79 | SLC7A5 (0.69) | SLC7A5PTGS1PKMALPIXIAP | |
| Tyrosine SCHEMBL246904 | 0.79 | SLC7A5 (0.96) | SLC7A5PTGS1PKMALPIXIAP | |
| Tyrosine SCHEMBL16893972 | 0.79 | SLC7A5 (0.96) | SLC7A5PTGS1PKMALPIXIAP | |
| Tyrosine SCHEMBL6488392 | 0.79 | SLC7A5 (0.96) | SLC7A5PTGS1PKMALPIXIAP | |
| Hydrochloric Acid SCHEMBL3873365 | 0.79 | SLC7A5 (0.69) | SLC7A5PTGS1PKMALPIXIAP | |
| Tyrosine SCHEMBL246905 | 0.79 | SLC7A5 (0.96) | SLC7A5PTGS1PKMALPIXIAP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120220649-A1 | MODIFIED DOUBLE-STRANDED POLYNUCLEOTIDE | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2012-08-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120220649-A1 | MODIFIED DOUBLE-STRANDED POLYNUCLEOTIDE | POLM, POLN, PNKP | SLC7A5 1944/4885PTGS1 4783/4885PKM 3839/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.